Corcept’s Phase III trial of ovarian cancer therapy shows PFS improvement
The trial outcomes are said to support a new drug application in the US and a European marketing authorisation application.

The trial outcomes are said to support a new drug application in the US and a European marketing authorisation application.
In the fast-paced world of medical communications, understanding reuse rights and copyright compliance is critical, particularly in today’s ever-evolving technological landscape.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The AI advantage in discovering new medicines
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline